IFNG and cancer: The efficacy of IFN-γ-driven antitumor responses depends on the intrinsic sensitivity of cancer cells to IFN-γ-induced cell death 66 and the capacity of IFN-γ receptor signaling to stabilize the immunologic synapse between CAR T cells and their targets 67.